Outcomes of MF Patients Exposure to Ruxolitinib During Transplantation
NCT04526223
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Time of Hematopoietic Reconstruction
Interventions
OTHER:
comprehensive treatment regimen
Sponsor
xuna